This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           Jan. 8, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

Recurrent ovarian cancers respond to cancer vaccine after 'reprogramming' with decitabine
Medical Xpress
Treatment with the drug decitabine prior to administration of chemotherapy and a cancer vaccine yielded clinical benefit for women with recurrent ovarian cancer, suggesting that this combinatorial chemoimmunotherapy may provide a new treatment option for patients with this disease, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




HPV


Tests of low-risk HPV types fail to detect later cancer risk
Medscape (Free login required)
Testing for low-risk human papillomavirus types should be excluded from cervical cancer screening because such tests fail to predict risk of developing cervical intraepithelial neoplasia grade 3 or worse, as well as expose women to potential harm; in addition, they have no proven benefit for patients, according to 2 large studies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HPV vaccine: The earlier, the better
MedPage Today
Women who were 18 and up or had abnormal cervical cytology when vaccinated against human papillomavirus subsequently had rates of cervical dysplasia similar to those of unvaccinated women, Canadian investigators reported.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  Work for the best

We are seeking a gyn-oncologist to join our growing health system in Springfield, Mo. Our clinic has on-site lab and radiology services, access to a da Vinci® surgical robot and a strong support staff. For more information about this opportunity at our physician owned and operated clinic, call 1-800-869-4201.
 


SGO ANNUAL MEETING


Annual Meeting early bird registration deadline Jan. 20
SGO
Save $175 by registering for SGO's 45th Annual Meeting on Women’s Cancer on or before Jan. 20. View the full list of member and nonmember rates and register online. Residents, students, senior and honorary members, and advocates are exempt from early bird pricing. The meeting runs March 22-25, 2014, in Tampa, FL.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


RESEARCH


Protein linked to breast cancer's spread to brain
Bioscience Technology
A cancer-research team at the University of Wisconsin-Madison has identified a protein that may be a major culprit when breast cancer metastasizes to the brain. Brain metastasis is a terrifying complication of advanced breast cancer, with a grim prognosis and few treatment options. The cancer's spread to the brain is often undetected until patients start to develop symptoms such as seizures, headaches, and trouble thinking.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Advertisement
A Medical
‘Must Have’

Morrow’s Gynecologic Cancer Surgery, 2nd Edition is an invaluable comprehensive surgical text book resource containing step-by-step written and illustrated descriptions of all the important operations in the field of gynecologic oncology.
Advertisement
Advertise here!

To find out how to feature your company in the SGO News Brief and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


6 cancer centers to share $540 million research gift
USA Today
In one of the largest-ever donations to cancer research, Ludwig Cancer Research of New York City announced today that it is contributing $540 million to try to resolve continuing mysteries about how cancer starts, spreads and can be thwarted. The unrestricted money for six cancer research centers established by earlier Ludwig donations is intended as a final gift from the philanthropy founded by the late Daniel Ludwig, a shipping magnate and real estate owner, which has now contributed $2.5 billion globally to cancer research.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer-fighting nanorobot may be able to target tumors, spare healthy tissue
CBS News
Could nanorobots be the next big cancer-fighting tool? Researchers from Chonnam National University in Gwangju, South Korea have created so-called "Bacteriobot," a genetically-modified non-toxic salmonella bacteria that delivers cancer treatments that target tumors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




NEW ANALYSIS


Why everyone seems to have cancer
The New York Times
Every New Year when the government publishes its Report to the Nation on the Status of Cancer, it is followed by a familiar lament. We are losing the war against cancer. Half a century ago, the story goes, a person was far more likely to die from heart disease. Now cancer is on the verge of overtaking it as the No. 1 cause of death.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin McNeely, Content Editor, 469.420.2692  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Jan. 3, 2013
Dec. 25, 2013
Dec. 18, 2013
Dec. 11, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063